| Biliary Disease |
0 |
0.97 |
| Hepatitis B Virus |
0 |
0.92 |
| HIV Infection |
0 |
0.58 |
| Hepatitis D |
0 |
1 |
| Hepatitis |
0 |
0.5 |
| Biologic Therapy |
0 |
0.49 |
| Liver |
0 |
0.46 |
| Aminotransferase |
0 |
0.44 |
| Liver Disease |
0 |
0.41 |
| Pegylated Interferon |
0 |
0.4 |
| Hypertension |
0 |
0.99 |
| Cirrhosis |
0 |
0.29 |
| Portal Hypertension |
0 |
0.23 |
| Viral Load |
0 |
0.23 |
| Antigens |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Antiviral Agents |
0 |
0.06 |
| Bile |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Immunoglobulin G (IgG) |
0 |
0.06 |
| Nucleotide Analog Reverse Transcriptase Inhibitors |
0 |
0.06 |
| Platelet Count |
0 |
0.06 |
| Pruritus |
0 |
0.06 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.05 |